Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Schering's reports disappointing diagnostic results:

This article was originally published in Clinica

Executive Summary

Schering's diagnostic sales fell by 6% to DM1,480 million ($865 million) in 1998, despite increased volume sales. Sales of X-ray contrast media were DM1,084 million, down 5%. This was largely due to government-imposed price cuts in Japan and the weakness of Asian currencies, the German company says. Pricing pressures caused by strong competition led to a 9% fall in sales of MRI contrast media to DM387 million. The Berlin-based company says its echo enhancement agent for ultrasound diagnosis, Levovist, "has still not recorded significant sales".

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT077794

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel